King Pharmaceuticals, Inc. v. Eon Labels, Inc
Court of Appeals for the Federal Circuit
1Opinion of the Court
GAJARSA, Circuit Judge.
King Pharmaceuticals, Inc. and King Pharmaceuticals Research and Development, Inc. (“King”) appeal the U.S. District Court for the Eastern District of New York’s grant of Eon Labs, Inc.’s (“Eon”) motion for summary judgment that all claims of U.S. Patent Nos. 6,407,128 (the “ '128 patent”) and 6,683,102 (the “ 102 patent”) are invalid. See King Pharms., Inc. v. Eon Labs, Inc., 593 F.Supp.2d 501 (E.D.N.Y.2009). In granting Eon’s motion, the district court held four claims invalid under 35 U.S.C. § 101, three claims invalid under 35 U.S.C. § 103, and the remaining claims…
2Cases cited36 opinions
- Anderson v. Liberty Lobby, Inc.Supreme Court of the United States · 1986
- Jenkins v. McKeithenSupreme Court of the United States · 1969
- Maryland Casualty Co. v. Pacific Coal & Oil Co.Supreme Court of the United States · 1941
- MedImmune, Inc. v. Genentech, Inc.Supreme Court of the United States · 2007
- KSR International Co. v. Teleflex Inc.Supreme Court of the United States · 2007
31 more not listed; retrieve them via the Exa API.
3Cited by67 opinions
- 3m Innovative Properties v. Tredegar CorporationCourt of Appeals for the Federal Circuit · 2013
- Tokai Corp. v. Easton Enterprises, Inc.Court of Appeals for the Federal Circuit · 2011
- Arris Group, Inc. v. British Telecommunications PLCCourt of Appeals for the Federal Circuit · 2011
- In Re Huai-Hung KaoCourt of Appeals for the Federal Circuit · 2011
- Meyer Intellectual Properties Ltd. v. Bodum, Inc.Court of Appeals for the Federal Circuit · 2012
62 more not listed; retrieve them via the Exa API.